Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
Clinical trial NCT05496075 · COMPLETED
Trial details
- NCT number
- NCT05496075
- Sponsor
- Shanghai 10th People's Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2023-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.